UBS’s MediciNova MNOV Stock Holding History

UBS’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$25K	Buy	+8,351	New	+$19.1K	﹤0.01%	7712
2014 Q2	–	Sell	-3,073	Closed	-$6K	–	10662
2014 Q1	$6K	Buy	+3,073	New	+$6.86K	﹤0.01%	9381

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

UBS's MNOV Position: Q3 2014 in Review

UBS opened a new position in MediciNova (MNOV) in Q3 2014: 8,351 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #7712 among its holdings. This is a return to the name: UBS previously reported a position in MNOV as recently as Q1 2014.

UBS first reported a position in MNOV in Q1 2014 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold MNOV as of Q3 2014.

UBS held 8,351 shares of MediciNova worth $25K as of Q3 2014.
MediciNova was a new UBS position in Q3 2014.
MediciNova made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7712 holding.
UBS first reported a position in MediciNova in Q1 2014 and has held it in 2 quarters since.
21 funds tracked by Wall St. Rank held MediciNova as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.